Hebei Hefeng Pharmaceutical Technology Co., Ltd. was established on March 20, 2020. The company is located in the Economic and Technological Development Zone of Shijiazhuang City, the capital of Hebei Province. It is a comprehensive enterprise that integrates the research and development, production, sales, and technical services of veterinary medicine products. The registered capital of the company is 90 million yuan, covering an area of 50000 square meters; There are eight new GMP production lines that can produce various dosage forms of products, including powder injections, water injections, premixes, powders, powders, oral solutions (including traditional Chinese medicine extraction), tablets/granules (including traditional Chinese medicine extraction production lines), etc. The annual output value can reach 1.5 billion yuan. The company relies on upstream raw materials to create a platform for the integration of animal medicine industry, providing higher cost-effective animal medicine formulation needs for breeding groups and farmers. At present, two series of advantageous varieties have been formed, namely beta lactam (potassium penicillin (sodium) for injection, amoxicillin sodium for injection, amoxicillin powder, etc.) and oxytetracycline (oxytetracycline hydrochloride injection, soluble doxycycline hydrochloride powder), providing better choices for the aquaculture industry.